Why it's doneBy Mayo Clinic staff
Noninvasive prenatal testing is much more sensitive and specific than traditional first and second trimester screening. As a result, noninvasive testing can often help women who have certain risk factors avoid invasive testing, such as:
- Amniocentesis. During this procedure, a small sample of the fluid that surrounds and protects the baby during pregnancy (amniotic fluid) is removed from the uterus for testing.
- Chorionic villus sampling (CVS). During CVS, a small sample of the wispy projections that are part of the developing placenta (chorionic villi) are removed from the placenta for testing.
Amniocentesis and CVS both carry a slight risk of miscarriage.
Your health care provider might recommend noninvasive prenatal testing first if:
- You have risk factors for having a baby who has a chromosomal condition. Noninvasive prenatal testing can determine whether your baby is at risk of a chromosomal condition. Risk factors might include older maternal age or having previously given birth to a baby who has Down syndrome, trisomy 13 or trisomy 18. Your health care provider also might recommend noninvasive prenatal testing if you've gotten worrisome results from another prenatal screening test.
- You're a carrier of an X-linked recessive disorder. X-linked recessive disorders, such as Duchenne's muscular dystrophy or a blood-clotting disorder (hemophilia), typically affect only males. Noninvasive prenatal testing can determine the sex of your baby earlier than an ultrasound. While noninvasive prenatal testing can determine your baby's sex, it won't determine if your baby has the disorder. Depending on your test results, a genetic counselor can help you understand the next steps.
- You have an Rh negative blood type. Noninvasive prenatal testing can determine your baby's Rh factor. If you're Rh negative and your baby is Rh positive, you might produce Rh antibodies after exposure to your baby's red blood cells. This is called becoming sensitized. (This is typically not a concern during a first pregnancy, but can be a concern during subsequent pregnancies.)
While noninvasive prenatal testing is currently recommended for women at high risk of carrying a baby who has a chromosomal abnormality, research is under way to see how it might be helpful for other women. Research is also being done to see what other chromosomal abnormalities and genetic conditions can be detected through this type of testing.
- National Society of Genetic Counselors Public Policy Committee, et al. Noninvasive prenatal testing/noninvasive prenatal diagnosis: The position of the National Society of Genetic Counselors. National Society of Genetic Counselors. http://www.nsgc.org/Advocacy/PositionStatements/tabid/107/Default.aspx. Accessed Dec. 7, 2012.
- Allyse M, et al. Cell-free fetal DNA testing for fetal aneuploidy and beyond: Clinical integration challenges in the US context. Human Reproduction. 2012;27:3123.
- Wright CF, et al. Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis. BMC Research Notes. 2012;5:476.
- Devaney SA, et al. Noninvasive fetal sex determination using cell-free fetal DNA: A systematic review and meta-analysis. Journal of the American Medical Association. 2011;306:627.
- Chiu RWK, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: Large scale validity study. British Medical Journal. 2011;342:c7401.
- Shulman LP. One small step and one giant leap for noninvasive prenatal screening: An editorial. American Journal of Obstetrics and Gynecology. 2011;204:183.
- Ehrich M, et al. Noninvasive detection of trisomy 21 by sequencing of DNA in maternal blood: A study in a clinical setting. American Journal of Obstetrics and Gynecology. 2011;204:205e1.
- Palomaki GE, et al. DNA sequencing of maternal plasma to detect Down syndrome: An international clinical validation study. Genetics in Medicine. 2011;13:913.
- Frequently asked questions. Pregnancy FAQ133. Routine tests in pregnancy. American College of Obstetrics and Gynecology. http://www.acog.org/~/media/For%20Patients/faq133.pdf?dmc=1&ts=20121207T1430460501. Accessed Dec. 7, 2012.
- Down syndrome overview. National Institute of Child Health & Human Development. http://www.nichd.nih.gov/health/topics/down/Pages/default.aspx. Accessed Dec. 7, 2012.
- Sehnert AJ, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clinical Chemistry. 2011;57:1042.
- What is Down syndrome? National Down Syndrome Society. http://www.ndss.org/Down-Syndrome/What-Is-Down-Syndrome/. Accessed Dec. 7, 2012.
- Diagnostic tests for birth defects. American College of Obstetrics and Gynecology. http://www.acog.org/Resources_And_Publications/Patient_Education_Pamphlets/Files/Diagnostic_Tests_for_Birth_Defects. Accessed Dec. 7, 2012.
- Rijinders RJP, et al. Clinical applications of cell-free fetal DNA from maternal plasma. Obstetrics and Gynecology. 2004;103:157.
- Wick Myra J (expert opinion). Mayo Clinic, Rochester, Minn. Dec. 22, 2012.
- The American College of Obstetricians and Gynecologists Committee on Genetics and the Society for Maternal-Fetal Medicine Publications Committee. Committee Opinion No. 545: Title of committee opinion. Obstetrics & Gynecology. 2012;120:1532.